Concepedia

The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis

Richard A. Robson, Adrian L. Buttimore, Kelvin L. Lynn, Mike Brewster, Penelope Ward

Nephrology Dialysis Transplantation · 2006 · 66 citations · 11 references

DOI

Abstract

A 30 mg dose of oseltamivir given once weekly in CAPD or after alternate sessions in HD patients provides sufficient exposure to oseltamivir carboxylate to allow safe and effective anti-influenza treatment and prophylaxis.

References

11

Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

John J. Treanor, Frederick G. Hayden, Peter S. Vrooman et al. · JAMA · 2000 · 1K citations

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

KG Nicholson, F. Y. Aoki, ADME Osterhaus et al. · The Lancet · 2000 · 781 citations

, , +4

Oral oseltamivir treatment of influenza in children

Richard J. Whitley, Frederick G. Hayden, Keith S. Reisinger et al. · The Pediatric Infectious Disease Journal · 2001 · 711 citations

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza

Frederick G. Hayden, John J. Treanor, Richard Fritz et al. · JAMA · 1999 · 554 citations

Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza

Frederick G. Hayden, Robert L. Atmar, M. Schilling et al. · New England Journal of Medicine · 1999 · 513 citations · Full text